Publication

Real-World Evidence That a Novel Diagnostic Combining Molecular Testing With Pooled Antibiotic Susceptibility Testing is Associated With Reduced Infection Severity and Lower Cost Compared With Standard Urine Culture in Patients With Complicated or Persistently Recurrent Urinary Tract Infections

JU Open Plus · Published 23 May 2023 · Dicken Ko, Emily Lukacz, Iver Allen Juster, Timothy Niecko, Aparna Ashok, Jean Annah Vollstedt, David Baunoch, Mohit Mathur.

In patients with recurrent urinary tract infections, rapid identification of pathogens and antibiotic susceptibilities using Guidance® UTI is associated with lower UTI-related clinical care and utilization costs compared with SUC.

Ready to see what better diagnostics can do for your practice?

Talk to a Pathnostics representative about Guidance® UTI and our other tests.

Talk to a Rep See Our Tests

Guidance UTI
with P-AST.

All Tests

Real-World Evidence That a Novel Diagnostic Combining Molecular Testing With Pooled Antibiotic Susceptibility Testing is Associated With Reduced Infection Severity and Lower Cost Compared With Standard Urine Culture in Patients With Complicated or Persistently Recurrent Urinary Tract Infections

Ready to see what better diagnostics can do for your practice?